|  | | | Editorial | Top | | The EMA Framework of Collaboration With Academic Stakeholders Anton Ussi and Giovanni Migliaccio Mol Ther 2016 24: 1883-1884; 10.1038/mt.2016.187 Full Text | | | | Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice Cy A Stein Mol Ther 2016 24: 1884-1885; 10.1038/mt.2016.188 Full Text | | In This Issue | Top | | In This Issue Mol Ther 2016 24: 1886; 10.1038/mt.2016.189 Full Text | | Research Highlights | Top | | Research Highlights Mol Ther 2016 24: 1887; 10.1038/mt.2016.190 Full Text | | Letters to the Editor | Top | | Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach Jacques P Tremblay, Jean-Paul Iyombe-Engembe, Benjamin Duchêne and Dominique L Ouellet Mol Ther 2016 24: 1888-1889; 10.1038/mt.2016.191 Full Text | | | | Prevention of Muscle Wasting by CRISPR/Cas9-mediated Disruption of Myostatin In Vivo Yuda Wei, Yanhao Chen, Yan Qiu, Huan Zhao, Gaigai Liu, Yongxian Zhang, Qingyang Meng, Guohao Wu, Yixiong Chen, Xiaolong Cai, Hui Wang, Hao Ying, Bin Zhou, Mingyao Liu, Dali Li and Qiurong Ding Mol Ther 2016 24: 1889-1891; 10.1038/mt.2016.192 Full Text | | Commentary | Top | | Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation Morton J Cowan and Hans-Peter Kiem Mol Ther 2016 24: 1892-1894; 10.1038/mt.2016.193 Full Text | | | | A New Agent in the Strategy to Cure AIDS John A Zaia Mol Ther 2016 24: 1894-1896; 10.1038/mt.2016.194 Full Text | | | | The Toughest Nut to Crack: Will We Ever Have a Preventive and Effective HIV-1 Vaccine? Zwi N Berneman Mol Ther 2016 24: 1896-1897; 10.1038/mt.2016.195 Full Text | | Original Articles | Top | | Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy Andrea Farini, Clementina Sitzia, Barbara Cassani, Letizia Cassinelli, Rosita Rigoni, Federica Colleoni, Nicola Fusco, Stefano Gatti, Pamela Bella, Chiara Villa, Filomena Napolitano, Rita Maiavacca, Silvano Bosari, Anna Villa and Yvan Torrente Mol Ther 2016 24: 1898-1912; advance online publication, August 10, 2016; 10.1038/mt.2016.162 Abstract | Full Text | | | | Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell ReceptorsMTOPEN Hongbing Yang, Sandrine Buisson, Giovanna Bossi, Zoë Wallace, Gemma Hancock, Chun So, Rebecca Ashfield, Annelise Vuidepot, Tara Mahon, Peter Molloy, Joanne Oates, Samantha J Paston, Milos Aleksic, Namir J Hassan, Bent K Jakobsen and Lucy Dorrell Mol Ther 2016 24: 1913-1925; advance online publication, June 6, 2016; 10.1038/mt.2016.114 Abstract | Full Text | | | | GDF11 Protects against Endothelial Injury and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Null Mice Wen Mei, Guangda Xiang, Yixiang Li, Huan Li, Lingwei Xiang, Junyan Lu, Lin Xiang, Jing Dong and Min Liu Mol Ther 2016 24: 1926-1938; advance online publication, August 9, 2016; 10.1038/mt.2016.160 Abstract | Full Text | | | | Viral Vector-Based Targeting of miR-21 in Cardiac Nonmyocyte Cells Reduces Pathologic Remodeling of the HeartMTOPEN Deepak Ramanujam, Yassine Sassi, Bernhard Laggerbauer and Stefan Engelhardt Mol Ther 2016 24: 1939-1948; advance online publication, August 22, 2016; 10.1038/mt.2016.166 Abstract | Full Text | | | | Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs Clementina Sitzia, Andrea Farini, Luciana Jardim, Paola Razini, Marzia Belicchi, Letizia Cassinelli, Chiara Villa, Silvia Erratico, Daniele Parolini, Pamela Bella, Joao Carlos da Silva Bizario, Luis Garcia, Marcelo Dias-Baruffi, Mirella Meregalli and Yvan Torrente Mol Ther 2016 24: 1949-1964; advance online publication, August 10, 2016; 10.1038/mt.2016.163 Abstract | Full Text | | | | In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice Séverine Ciré, Sylvie Da Rocha, Maxime Ferrand, Mary K Collins and Anne Galy Mol Ther 2016 24: 1965-1973; advance online publication, August 26, 2016; 10.1038/mt.2016.168 Abstract | Full Text | | | | Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer PainMTOPEN Ling Jin, Yosuke Nonaka, Shin Miyakawa, Masatoshi Fujiwara and Yoshikazu Nakamura Mol Ther 2016 24: 1974-1986; advance online publication, August 10, 2016; 10.1038/mt.2016.158 Abstract | Full Text | | | | Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy Jenessa B Smith, Evripidis Lanitis, Denarda Dangaj, Elizabeth Buza, Mathilde Poussin, Caitlin Stashwick, Nathalie Scholler and Daniel J Powell, Jr Mol Ther 2016 24: 1987-1999; advance online publication, July 21, 2016; 10.1038/mt.2016.149 Abstract | Full Text | | | | Contributions of Mouse and Human Hematopoietic Cells to Remodeling of the Adult Auditory Nerve After Neuron LossMTOPEN Hainan Lang, Eishi Nishimoto, Yazhi Xing, LaShardai N Brown, Kenyaria V Noble, Jeremy L Barth, Amanda C LaRue, Kiyoshi Ando and Bradley A Schulte Mol Ther 2016 24: 2000-2011; advance online publication, September 7, 2016; 10.1038/mt.2016.174 Abstract | Full Text | | | | Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses Ans De Beuckelaer, Charlotte Pollard, Sandra Van Lint, Kenny Roose, Lien Van Hoecke, Thomas Naessens, Vimal Kumar Udhayakumar, Muriel Smet, Niek Sanders, Stefan Lienenklaus, Xavier Saelens, Siegfried Weiss, Guido Vanham, Johan Grooten and Stefaan De Koker Mol Ther 2016 24: 2012-2020; advance online publication, August 10, 2016; 10.1038/mt.2016.161 Abstract | Full Text | | | | Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus MacaquesMTOPEN Donatella Negri, Maria Blasi, Celia LaBranche, Robert Parks, Harikrishnan Balachandran, Michelle Lifton, Xiaoying Shen, Thomas Denny, Guido Ferrari, Maria Fenicia Vescio, Hanne Andersen, David C Montefiori, Georgia D Tomaras, Hua-Xin Liao, Sampa Santra, Barton F Haynes, Mary E Klotman and Andrea Cara Mol Ther 2016 24: 2021-2032; advance online publication, June 21, 2016; 10.1038/mt.2016.123 Abstract | Full Text | | Corrigendum | Top | | Corrigendum to “Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma” Mol Ther 2016 24: 2033; 10.1038/mt.2016.196 Full Text | | | Advertisement | | | | | | | | Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | |
No comments:
Post a Comment